Joseph Schroers-Martin

Employment

• Stanford University Assistant Professor
  2024 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (49)

• Second-line CD19 CAR T vs platinum salvage and autologous stem cell transplant for primary mediastinal B-cell lymphoma
  Blood Advances 2026 DOI: 10.1182/bloodadvances.2026020965
  +Save
• Digging deep for the roots of lymphoma
  Blood 2026 DOI: 10.1182/blood.2025032718
  +Save
• Data from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
  2025 DOI: 10.1158/2159-8290.c.6649130
  +Save
• Supplementary Methods & Figures S1-S5 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
  2025 DOI: 10.1158/2159-8290.30859505
  +Save
• Supplementary Tables S1-S15 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
  2025 DOI: 10.1158/2159-8290.30859502
  +Save
• Integrating Novel Agents Into the Clinical Management of Classic Hodgkin Lymphoma
  JCO Oncology Practice 2025 DOI: 10.1200/OP.24.00277
  +Save
• Cell-Free DNA in Hematologic Malignancies
  Joseph G. Schroers‐Martin, Ash A. Alizadeh
  JCO Oncology Practice 2024 DOI: 10.1200/OP-24-00648
  +Save
• Data from Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors
  2024 DOI: 10.1158/2159-8290.c.6649130.v3
  +Save
• Supplementary Methods & Figures S1-S5 from Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors
  2024 DOI: 10.1158/2159-8290.27025259.v1
  +Save
• Supplementary Methods & Figures S1-S5 from Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors
  2024 DOI: 10.1158/2159-8290.27025259
  +Save
• Supplementary Tables S1-S15 from Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors
  2024 DOI: 10.1158/2159-8290.27025256.v1
  +Save
• Supplementary Tables S1-S15 from Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors
  2024 DOI: 10.1158/2159-8290.27025256
  +Save
• The role of response adapted therapy in the era of novel agents
  Seminars in Hematology 2024 DOI: 10.1053/j.seminhematol.2024.06.002
  +Save
• Long‐term outcome of peripheral T‐cell lymphomas: Ten‐year follow‐up of the International Prospective T‐cell Project
  British Journal of Haematology 2024 DOI: 10.1111/bjh.19433
  +Save
• Data from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
  2023 DOI: 10.1158/2159-8290.c.6649130.v2
  +Save
• Supplementary Methods & Figures S1-S5 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
  2023 DOI: 10.1158/2159-8290.23283246.v1
  +Save
• Supplementary Methods & Figures S1-S5 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
  2023 DOI: 10.1158/2159-8290.23283246
  +Save
• Supplementary Tables S1-S15 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
  2023 DOI: 10.1158/2159-8290.23283243
  +Save
• Supplementary Tables S1-S15 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
  2023 DOI: 10.1158/2159-8290.23283243.v1
  +Save
• Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
  Joseph G. Schroers‐Martin, Joanne Soo, Gabriel Brisou +16 more
  Cancer Discovery 2023 DOI: 10.1158/2159-8290.CD-23-0111
  +Save